Target Audience
This activity was developed for primary care physicians, gastroenterologists, physician assistants, nurse practitioners, nurses and other healthcare professionals who have an interest in IBS treatment.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Establish a timely diagnosis of IBS based upon diagnostic criteria
- Incorporate shared decision-making and individualized patient education into clinical encounter
- Individualize treatment plans for patients with IBS-C based upon clinical data, guidelines, and recommendations
- Tailor treatment plans for patients with IBS-D based upon best available evidence on current therapies, clinical guidelines, and recommendations
Faculty
William D. Chey, MD
Nostrant Professor of Medicine
Director of the Digestive Disorders
Nutrition & Lifestyle Program
Division of Gastroenterology
University of Michigan Health System
Ann Arbor, Michigan
Amy Foxx-Orenstein, DO, MACG, FACP
Professor of Medicine
Consultant, Division of Gastroenterology and Hepatology
Co-Director of Motility
Mayo Clinic, Scottsdale, Arizona
Accreditation and Certification
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of
1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of
1.50 contact hours
may be earned for successful completion of this activity.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for
1.50 contact hours.
Accreditation:
The American Osteopathic Association (AOA) Council on Osteopathic Continuing Medical Education has designated the American Osteopathic Association Bureau of OMED as the accredited CME sponsor.
This activity has been planned and implemented through the collaboration of the American Osteopathic Association and Annenberg Center for Health Sciences at Eisenhower.
Credit Designation:
The American Osteopathic Association Bureau of OMED has designated this virtual program for a maximum of 1.5 AOA Category 1-B credit and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
- Participants who successfully complete the evaluation and the post-test (scoring 70% or higher in a maximum of 3 attempts) will receive Category 1.5 Category 1-B CME credit.
Contacts:
For information regarding the editorial content of this program, contact Walter Wachel, Assistant Director of Industry Relations and Project Development at wwachel@osteopathic.org.
For questions regarding CME, please contact the American Osteopathic Association: crc@osteopathic.org or 800-621-1773, ext. 8262.
Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:
William D. Chey, MD
- Research Support: Biomerica, Ironwood, Nestlé
- Consultant: Allergan, Biomerica, IM Health, Ironwood, Nestlé, Ritter, Salix
Amy Foxx-Orenstein, DO, MACG, FACP
- No significant relationships to disclose
The faculty for this activity has disclosed that there will be
no
discussion about the use of products for non-FDA approved indications.
Additional Content Planners
Cris Fischer, MSc (medical writer): No significant relationships to disclose.
Heather Jimenez, BSN, MSN (lead nurse planner): No significant relationships to disclose.
Eugene Cullen, MD (peer reviewer): No significant relationships to disclose.
Annenberg Center for Health Sciences
Charles Willis, Director, Continuing Education, consults for Pfizer, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
This activity is supported by independent educational grants from Allergan, Ironwood Pharmaceuticals and Salix.
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component.
The estimated time to complete the activity is
1.50 hours.
This activity was originally released on
April 15, 2018 and is eligible for credit through
April 14, 2019.
Our Policy on Privacy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/
Contact Information
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
ce@annenberg.net
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday
